Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment

Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment

Despite the rapid developments and advancements to improve treatments, Breast cancer remains one of the deadliest health challenges and the most frequently diagnosed tumor. One of the major problems with treatment is the unique difference that each cancerous cell exhibits. As a result, treatment of...

Full description

Bibliographic Details
Main Authors: Precious A Akinnusi, Samuel O Olubode, Ayomide O Adebesin, Toluwani A Nana, Sidiqat A Shodehinde
Format: Article
Language:English
Published: SAGE Publishing 2022-10-01
Series:Cancer Informatics
Online Access:https://doi.org/10.1177/11769351221127862

Similar Items

Similar Items